Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Stimulator of interferon genes protein (STING)-TANK-binding kinase 1 (TBK1) complex is a critical signaling assembly in the cGAS-STING pathway, essential for the induction of innate immune responses to cytosolic DNA. Upon activation by cyclic dinucleotides like cGAMP, STING translocates from the endoplasmic reticulum to the Golgi, where its C-terminal tail recruits TBK1 (Liu et al., 2015, Science; Tanaka & Chen, 2012, Science Signaling). This interaction facilitates the phosphorylation of STING and the transcription factor IRF3 by TBK1, ultimately triggering the production of Type I interferons and pro-inflammatory cytokines (Motwani et al., 2019, Nature Reviews Genetics). In oncology, this complex is a major therapeutic target, with STING agonists being developed to promote its formation and stimulate anti-tumor immunity (Decout et al., 2021, Nature Reviews Immunology). Conversely, overactivation of the STING-TBK1 complex is implicated in autoinflammatory diseases such as STING-associated vasculopathy with onset in infancy (SAVI) and systemic lupus erythematosus, leading to research into inhibitors that disrupt this specific protein-protein interface (Barber, 2015, Nature Reviews Immunology). Targeting the complex directly or its individual components allows for the modulation of the immune system in both cancer and inflammatory contexts.
Agonism of STING to induce complex formation or inhibition of TBK1 to prevent complex-mediated signaling.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stimulator of interferon genes protein (STING)-TANK-binding kinase 1 (TBK1) complex (STING-TBK1 complex).